POINT BIOPHARMA
POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and commercialization of radioligands that fight cancer. POINT Biopharma Global Inc. is combining a portfolio of best-in-class radiopharmaceutical assets, a seasoned management team, expertise in radioisotopes such as Actinium-225 (Ac-225) and Lutetium-177 (Lu-177), manufacturing technology and novel direct-to-patient targeting to revolutionize theragnostic drug development and radioligand commercialization.
POINT BIOPHARMA
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Indianapolis, Indiana, United States
Country:
United States
Website Url:
http://www.pointbiopharma.com
Total Employee:
11+
Status:
Active
Contact:
(317) 543-9957
Total Funding:
165 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Regenxcel
A CDMO to enable the development and commercialization of cell-based therapies for regenerative medicine technologies.
Current Employees Featured
Founder
Stock Details
Investors List
Farallon Capital Management
Farallon Capital Management investment in Post-IPO Equity - Point Biopharma
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund investment in Post-IPO Equity - Point Biopharma
Woodline Partners
Woodline Partners investment in Post-IPO Equity - Point Biopharma
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Point Biopharma
Suvretta Capital Management
Suvretta Capital Management investment in Post-IPO Equity - Point Biopharma
BVF Partners
BVF Partners investment in Post-IPO Equity - Point Biopharma
Boxer Capital
Boxer Capital investment in Post-IPO Equity - Point Biopharma
Surveyor Capital
Surveyor Capital investment in Post-IPO Equity - Point Biopharma
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Post-IPO Equity - Point Biopharma
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Point Biopharma
Key Employee Changes
Official Site Inspections
http://www.pointbiopharma.com Semrush global rank: 2.43 M Semrush visits lastest month: 7.44 K
- Host name: redirector.1brandsight.net
- IP address: 18.217.251.129
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
